Biotech Investor Relations & Corporate Communications Leader

Hemab Therapeutics; Cambridge (MA); Hybrid; USD 180,000 - 280,000; Full time

Job summary

Hemab Therapeutics in Cambridge, MA, seeks a seasoned Vice President, Investor Relations & Corporate Communications to lead IR and communications strategy. The role partners with the CEO and CFO, shaping messaging for investors, employees, patients, and the media across dual hubs in Cambridge and Copenhagen.

This hands-on executive role builds processes and mentors teams to scale with the company’s growth. Experience guiding public-company communication, SEC disclosures, and data-driven

Qualifications

• Senior communications leadership in biotech.
• Translate complex science data into clear comms.
• Experience with SEC disclosure and Reg FD.
• Experience advising CEOs/CFOs on communications.
• Strong writing and editorial judgement.
• Investor relations for a public company.

Responsibilities

• Build and lead Hemab's communications function with clear ownership.
• Turn complex science and milestones into compelling communications for stakeholders.
• Set corporate narrative and forward-looking calendar for proactive messaging.
• Run day-to-day investor relations in partnership with CFO and CEO.
• Oversee external communications and agency relationships.

Skills

Executive leadership

Science storytelling

IR experience

Medical Affairs collaboration

SEC disclosure knowledge

Executive advising

Job description

Hemab Therapeutics in Cambridge, MA, seeks a seasoned Vice President, Investor Relations & Corporate Communications to lead IR and communications strategy. The role partners with the CEO and CFO, shaping messaging for investors, employees, patients, and the media across dual hubs in Cambridge and Copenhagen.

This hands-on executive role builds processes and mentors teams to scale with the company’s growth. Experience guiding public-company communication, SEC disclosures, and data-driven